| Key Financial Ratios of Bliss GVS Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
9.43 |
11.99 |
5.70 |
7.95 |
8.00 |
|
| Diluted EPS (Rs.) |
9.43 |
11.99 |
5.70 |
7.95 |
8.00 |
|
| Cash EPS (Rs.) |
10.46 |
13.15 |
10.67 |
12.88 |
10.99 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
72.75 |
63.97 |
53.10 |
53.61 |
43.21 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
72.75 |
63.97 |
53.10 |
53.61 |
43.21 |
|
| Revenue from Operations/Share (Rs.) |
66.83 |
87.08 |
78.98 |
77.41 |
53.02 |
|
| PBDIT/Share (Rs.) |
15.75 |
18.93 |
21.69 |
20.87 |
17.42 |
|
| PBIT/Share (Rs.) |
14.53 |
18.06 |
19.61 |
18.91 |
16.13 |
|
| PBT/Share (Rs.) |
12.50 |
17.64 |
14.09 |
17.01 |
14.37 |
|
| Net Profit/Share (Rs.) |
9.23 |
12.28 |
8.60 |
10.92 |
9.71 |
|
| NP After MI And SOA / Share (Rs.) |
9.43 |
11.99 |
5.70 |
7.95 |
8.00 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
23.57 |
21.73 |
27.45 |
26.95 |
32.84 |
|
| PBIT Margin (%) |
21.74 |
20.74 |
24.83 |
24.43 |
30.42 |
|
| PBT Margin (%) |
18.70 |
20.25 |
17.83 |
21.96 |
27.09 |
|
| Net Profit Margin (%) |
13.81 |
14.10 |
10.88 |
14.11 |
18.31 |
|
| NP After MI And SOA Margin (%) |
14.11 |
13.77 |
7.21 |
10.27 |
15.08 |
|
| Return on Networth/Equity (%) |
13.22 |
19.15 |
10.96 |
16.86 |
19.98 |
|
| Return on Capital Employed (%) |
18.81 |
26.70 |
36.08 |
33.30 |
16.65 |
|
| Return on Assets (%) |
9.45 |
13.67 |
6.83 |
8.02 |
10.82 |
|
| Total Debt/Equity (X) |
0.14 |
0.15 |
0.21 |
0.44 |
0.24 |
|
| Asset Turnover Ratio (%) |
66.98 |
99.26 |
94.72 |
78.05 |
71.79 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.33 |
3.35 |
2.30 |
1.29 |
1.77 |
|
| Quick Ratio (X) |
3.01 |
2.98 |
2.11 |
1.18 |
1.62 |
|
| Inventory Turnover Ratio (X) |
9.30 |
11.61 |
13.80 |
16.20 |
14.14 |
|
| Dividend Payout Ratio (NP) (%) |
12.78 |
10.07 |
12.67 |
7.56 |
6.36 |
|
| Dividend Payout Ratio (CP) (%) |
11.31 |
9.39 |
9.29 |
6.07 |
5.48 |
|
| Earnings Retention Ratio (%) |
87.22 |
89.93 |
87.33 |
92.44 |
93.64 |
|
| Cash Earnings Retention Ratio (%) |
88.69 |
90.61 |
90.71 |
93.93 |
94.52 |
|
| Coverage Ratios |
|
|
|
|
|
|
| Interest Coverage Ratios (%) |
19.81 |
42.21 |
8.87 |
9.91 |
9.14 |
|
| Interest Coverage Ratios (Post Tax) (%) |
19.81 |
42.21 |
8.87 |
9.91 |
9.14 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,054.79 |
1,860.20 |
2,049.17 |
1,948.45 |
1,363.19 |
|
| EV/Net Operating Revenue (X) |
1.53 |
2.07 |
2.52 |
2.44 |
2.49 |
|
| EV/EBITDA (X) |
6.49 |
9.53 |
9.16 |
9.05 |
7.59 |
|
| MarketCap/Net Operating Revenue (X) |
1.51 |
2.07 |
2.47 |
2.28 |
2.39 |
|
| Retention Ratios (%) |
87.21 |
89.92 |
87.32 |
92.43 |
93.63 |
|
| Price/BV (X) |
1.41 |
2.87 |
3.76 |
3.74 |
3.17 |
|
| Price/Net Operating Revenue |
1.51 |
2.07 |
2.47 |
2.28 |
2.39 |
|
| Earnings Yield |
0.09 |
0.07 |
0.03 |
0.05 |
0.06 |
|
Source : Dion Global Solutions Limited
